Details

Autor(en) / Beteiligte

• Xu, Min
• Zhao, Zhiyun
• Shen, Feixia
• Hu, Ruying
• Lu, Jieli
• Xu, Yu
• Wang, Tiange
• Li, Mian
• Chen, Gang
• Chen, Li
• Chen, Lulu
• Chen, Yuhong
• Deng, Huacong
• Gao, Zhengnan
• Huo, Yanan
• Li, Qiang
• Liu, Chao
• Luo, Zuojie
• Mu, Yiming
• Qin, Guijun
• Qin, Yingfen
• Shi, Lixin
• Su, Qing
• Wan, Qin
• Wang, Guixia
• Wang, Shuangyuan
• Wang, Youmin
• Wu, Shengli
• Xu, Yiping
• Yan, Li
• Yang, Tao
• Ye, Zhen
• Yu, Xuefeng
• Zhang, Yinfei
• Zhao, Jiajun
• Zeng, Tianshu
• Wang, Weiqing
• Bi, Yufang
• Tang, Xulei
• Ning, Guang

Titel

Modification effect of changes in cardiometabolic traits in association between kidney stones and cardiovascular events

Ist Teil von

• Frontiers in cardiovascular medicine, 2022-07, Vol.9, p.923981-923981

Ort / Verlag

Frontiers Media S.A

Erscheinungsjahr

2022

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Backgrounds Whether longitudinal changes in metabolic status influence the effect of kidney stones on cardiovascular disease (CVD) remains unclarified. We investigated the modification effect of status changes in metabolic syndrome (MetS) in the association of kidney stones with risk of incident CVD events. Methods We performed a prospective association and interaction study in a nationwide cohort including 129,172 participants aged ≥ 40 years without CVDs at baseline and followed up for an average of 3.8 years. Kidney stones information was collected by using a questionnaire and validated by medical records. The repeated biochemical measurements were performed to ascertain the metabolic status at both baseline and follow-up. Results 4,017 incident total CVDs, 1,413 coronary heart diseases (CHDs) and 2,682 strokes were documented and ascertained during follow-up. Kidney stones presence was significantly associated with 44%, 70% and 31% higher risk of CVDs, CHDs and stroke, respectively. The stratified analysis showed significant associations were found in the incident and sustained MetS patients, while no significant associations were found in the non-MetS at both baseline and follow-up subjects or the MetS remission ones, especially in women. For the change status of each single component of the MetS, though the trends were not always the same, the associations with CVD were consistently significant in those with sustained metabolic disorders, except for the sustained high blood glucose group, while the associations were consistently significant in those with incident metabolic disorders except for the incident blood pressure group. We also found a significant association of kidney stone and CVD or CHD risk in the remain normal glucose or triglycerides groups; while the associations were consistently significant in those with incident metabolic disorders except for the incident blood pressure group. We also found a significant association of kidney stone and CVD or CHD risk in the remain normal glucose or triglycerides groups. Conclusions A history of kidney stones in women with newly developed MetS or long-standing MetS associated with increased risk of CVD. The mechanisms link kidney stones and CVD risk in the metabolic and non-metabolic pathways were warranted for further studies.